AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 01/12/21

Amneal Pharmaceuticals (AMRX) announced that Amneal Pharmaceuticals LLC, a wholly-owned subsidiary of the company will be acquiring a 98% interest in Kashiv Specialty Pharmaceuticals, a wholly-owned subsidiary of Kashiv BioSciences.Kashiv Specialty Pharmaceuticals is focused on the devel...

Amneal Pharmaceuticals (AMRX) inks agreement to acquire a 98% interest in Kashiv BioSciences. Under the terms of the transaction, Amneal will pay an upfront purchase price of $70M at the closing of the acquisition and $30M at the one-year anniversary of the execution of the deal.Kas...

Amneal Pharmaceuticals, Inc. (the “ Company ”) (NYSE:AMRX) and Kashiv BioSciences LLC (“ Kashiv ”) today announced they have entered into a definitive agreement under which Amneal Pharmaceuticals LLC (“ Amneal ”), a wholly-owned subs...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) announced that it has received approval of an additional strength of 500 mg to its Abbreviated New Drug Application (ANDA), from the U.S. Food and Drug Administration (FDA) for Abiraterone ...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that Chirag Patel, Amneal’s Co-Chief Executive Officer and President, will present at the 39 th Annual J.P. Morgan Healthcare Conference on January 13, 2021 at 2:50 PM Eastern Time. A live...

The FDA has approved Amneal Pharmaceuticals' ([[AMRX]]) Abbreviated New Drug Application ((ANDAs)) for Acyclovir Cream, 5% a generic version of Zovirax for treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years and older.The product is...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) today announced that it has received approval for its Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA) for Acyclovir Cream, 5%. Acyclovir Cream, 5%, is the generic version of Zovir...

Image source: The Motley Fool. Amneal Pharmaceuticals, Inc. (NYSE: AMRX) Q3 2020 Earnings Call Nov 6, 2020 , 8:30 a.m. ET Operator Continue reading For further details see: Amneal Pharmaceuticals, Inc. (AMRX) Q3 2020 Earnings Call Transcr...

Amneal Pharmaceuticals, Inc. (AMRX) Q3 2020 Earnings Conference Call November 06, 2020 08:30 AM ET Company Participants Tasos Konidaris - Chief Financial Officer Chirag Patel - Co-Chief Executive Officer Chintu Patel - Co-Chief Executive Officer Conference Call Participants David Amsellem - P...

The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Amneal Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call Presentation